Win the Fight Against
Prostate Cancer
Men diagnosed with Intermediate to High Risk Prostate Cancer are more likely to have cancer return, Relapse or Recurrence, in the years following treatment. Experts have done the research to find which initial prostate cancer treatments help patients increase the odds of remission after treatment. Explore the data and understand your treatment options.
You have a choice! Choose your RISK GROUP and compare outcomes.
Compare Treatment Success Rates
Low
Intermediate
High
DON’T KNOW YOUR RISK GROUP? FIND OUT HERE
Disclaimer: Prostate Cancer Treatment Results will vary from person to person.
LEARN TO FIGHT PROSTATE CANCER
Top Ten Steps - Fight Prostate Cancer
Learn the Top Ten Steps, a guide through knowledge about the prostate, prostate cancer, diagnosis and treatment. Watch our video, introducing Edward Weber, MD. and hear his advice to men just diagnosed with prostate cancer. Get expert advice for your fight against Prostate Cancer.
PROSTATE CANCER FREE VIDEO LIBRARY.
UNDERSTANDING PROSTATE CANCER
What is Prostate Cancer?
What is Prostate Cancer, the Symptoms, Risk Factors? What does the Prostate do, where is it located?
Prostate Cancer Recurrence.
For Some, Cancer Returns After Treatment. Compare Treatments. Increase Your Odds of Remaining in Remission.
Treating Prostate Cancer.
Patients have options when it comes to the prostate cancer treatments. Learn about your options.
PROSTATE CANCER FREE MISSION
The Prostate Cancer Free Foundation is here to help you quickly learn about the prostate gland, cancer of the prostate, prostate cancer treatments and treatment side effects. If you are recently diagnosed with prostate cancer, you have a choice in your prostate cancer treatment. If diagnosed early, there are many options. The decision can be more complicated for patients with more advanced disease where the risk of cancer relapse is greatly increased. Relapse or recurrence is the return of cancer, requiring additional treatment. This website features information to help you determine which prostate cancer treatments are the most successful at eliminating localized cancer. Increase the odds of remaining prostate cancer free for the rest of your life.
When prostate cancer is discovered early, the risk of relapse of recurrence can be low. But if you have been diagnosed with cancer that has spread, or is more aggressive, you may fall into the Intermediate to High Risk Group. For men in these groups, choosing the best treatment, or combination of treatments provides the best chance to remain in remission following treatment. Recurrence is discovered by regularly scheduled PSA blood tests, at established intervals following treatment. Prostate Cancer Free offers a study comparing the different prostate cancer treatment outcomes for over 129,000 men, highlighting which men remained in remission and for how many years. See which treatments are most likely to keep men in remission, with no return of cancer.
The Prostate Cancer Free Foundation is a NON-PROFIT 501-C. The Foundation is completely dependent upon donations. Your tax deductible donation(s) enables the Foundation to continue the valuable work of educating men and their loved ones about prostate cancer.
PROSTATE CANCER NEWS
PCa Commentary #167 – PROVENGE – AN UPDATE: What Has Been Learned Since FDA Approval in 2010?
Provenge (Dendreon, Inc, ‘Sipuleucel-T’) is an autologous (i.e., based on a patient’s own cells) vaccine targeted to the highly expressed prostatic acid phosphatase (PAP) antigen on malignant prostate cells. It was FDA approved based on the IMPACT trial reporting a...
PCa Commentary #166 – CAR-T Cell IMMUNOTHERAPY OF PROSTATE CANCER: Promising, but Currently Only a “Work-in-Progress.”
Years before there was even a glimmer of technical possibility for effective immunotherapy, there was great hope for harassing the immune system to combat cancer. The earliest realization of this hope came with the FDA approval of Provenge in April 2010 and...
PCa Commentary #165 – Lutetium-177—PSMA-617 Therapy: Now FDA approved and to be available shortly: The Treatment in Context
[Prostate Cancer Commentary Vol. 143 PCa Commentary #143: ANTI-PSMA 177-LUTETIUM RADIOLIGAND THERAPY discusses the mechanism of action of 177Lu therapy, its background and outcome of early studies] (control+click above link to follow or visit...
Remission versus Recurrence?
Relapse of prostate cancer is way more common than you might think. Many men treated for prostate cancer have their cancer return, which can lead to a lifetime of treatment. Prostate Cancer Free studies treatment outcomes documented in "The STUDY", recently updated for 2021. Take this Study to your doctor, and discuss your chance of cancer recurrence. The Study is available with the new, just released booklet, to help you learn about prostate cancer. Both the Prostate Cancer Free Study and the booklet, “What You Need to Know About Prostate Cancer” are available NOW for you to VIEW, PRINT or DOWNLOAD.
Help To Continue the Work!
The Prostate Cancer Free Foundation, reviews the results of hundreds of thousands of men treated for prostate cancer. Tracking them for years. This information is available to you, and others like you, to help find the best prostate cancer treatment. This work takes time, effort, resources all of it done by volunteers. Please help us continue. Please Donate!